| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |